DNX Biopharmaceuticals Overview
- Founded
-
2014
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Angel
- (Cancelled)
- Latest Deal Amount
-
$5M
- Investors
-
1
DNX Biopharmaceuticals General Information
Description
Owner and operator of a biopharmaceutical company intended to develop long-acting therapeutic proteins for the treatment of patients with life-long diseases. The company's biopharmaceutical services focus on development of new therapeutic proteins utilizing a half-life extension platform that produces therapeutic proteins and biological drugs to treat auto-inflammatory diseases, enabling medical researchers to facilitate treatment of rheumatoid arthritis and other related diseases, while off-setting the development cost through therapeutic proteins and biological drugs.
Contact Information
Website
www.dnxbio.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
- 19800 MacArthur Boulevard
- Suite 300
- Irvine, CA 92612
- United States
+1 (949) 000-0000
DNX Biopharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Angel (individual) | 01-Jul-2016 | $5M | Cancelled | Startup | ||
| 1. Accelerator/Incubator | 14-May-2016 | Completed | Startup |
DNX Biopharmaceuticals Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Rajiv Datar Ph.D | Co-Founder & Chief Executive Officer | ||
| Claude Gingras | Chief Financial Officer | ||
| Jeff Hale | Chief Business Officer | ||
| John Caputo | Co-Founder & Board Member |
DNX Biopharmaceuticals Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Howard Levine Ph.D | DNX Biopharmaceuticals | Co-Founder & Board Member | 000 0000 |
| John Caputo | DNX Biopharmaceuticals | Co-Founder & Board Member | 000 0000 |
| Thomas Zindrick JD | Self | Board Member | 000 0000 |
DNX Biopharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
DNX Biopharmaceuticals Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| EvoNexus | Accelerator/Incubator | 000 0000 | 000000 0 |